BIOMAT Database Logo BIOMAT Database Logo

Liver transplantation in severe von Willebrand disease. 1991

P Mannuccio Mannucci, and A Federici, and M Cattaneo, and R Fassati, and D Galmarini

UI MeSH Term Description Entries
D008297 Male Males
D001760 Bleeding Time Duration of blood flow after skin puncture. This test is used as a measure of capillary and platelet function. Aspirin Tolerance Test,Bleeding Time, Template,Duke Method,Ivy Method,Template Bleeding Time,Aspirin Tolerance Tests,Bleeding Times,Bleeding Times, Template,Method, Duke,Method, Ivy,Template Bleeding Times,Test, Aspirin Tolerance,Tests, Aspirin Tolerance,Time, Bleeding,Time, Template Bleeding,Times, Bleeding,Times, Template Bleeding,Tolerance Test, Aspirin,Tolerance Tests, Aspirin
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014841 von Willebrand Factor A high-molecular-weight plasma protein, produced by endothelial cells and megakaryocytes, that is part of the factor VIII/von Willebrand factor complex. The von Willebrand factor has receptors for collagen, platelets, and ristocetin activity as well as the immunologically distinct antigenic determinants. It functions in adhesion of platelets to collagen and hemostatic plug formation. The prolonged bleeding time in VON WILLEBRAND DISEASES is due to the deficiency of this factor. Factor VIII-Related Antigen,Factor VIIIR-Ag,Factor VIIIR-RCo,Plasma Factor VIII Complex,Ristocetin Cofactor,Ristocetin-Willebrand Factor,von Willebrand Protein,Factor VIII Related Antigen,Factor VIIIR Ag,Factor VIIIR RCo,Ristocetin Willebrand Factor
D014842 von Willebrand Diseases Group of hemorrhagic disorders in which the VON WILLEBRAND FACTOR is either quantitatively or qualitatively abnormal. They are usually inherited as an autosomal dominant trait though rare kindreds are autosomal recessive. Symptoms vary depending on severity and disease type but may include prolonged bleeding time, deficiency of factor VIII, and impaired platelet adhesion. Angiohemophilia,Hemophilia, Vascular,von Willebrand Disease,Vascular Pseudohemophilia,Von Willebrand Disorder,Von Willebrand's Factor Deficiency,von Willebrand Disease, Recessive Form,von Willebrand's Disease,von Willebrand's Diseases,Angiohemophilias,Disorder, Von Willebrand,Pseudohemophilia, Vascular,Pseudohemophilias, Vascular,Vascular Hemophilia,Vascular Hemophilias,Vascular Pseudohemophilias
D016031 Liver Transplantation The transference of a part of or an entire liver from one human or animal to another. Grafting, Liver,Hepatic Transplantation,Liver Transplant,Transplantation, Hepatic,Transplantation, Liver,Hepatic Transplantations,Liver Grafting,Liver Transplantations,Liver Transplants,Transplant, Liver

Related Publications

P Mannuccio Mannucci, and A Federici, and M Cattaneo, and R Fassati, and D Galmarini
Liver Transplantation in Type III von Willebrand Disease.
June 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
P Mannuccio Mannucci, and A Federici, and M Cattaneo, and R Fassati, and D Galmarini
Modification of von Willebrand disease after liver transplantation.
December 2001, Thrombosis and haemostasis,
P Mannuccio Mannucci, and A Federici, and M Cattaneo, and R Fassati, and D Galmarini
Liver transplantation for severe von Willebrand's disease.
June 1991, Lancet (London, England),
P Mannuccio Mannucci, and A Federici, and M Cattaneo, and R Fassati, and D Galmarini
Development of a severe von Willebrand factor/ADAMTS13 dysbalance during orthotopic liver transplantation.
May 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
P Mannuccio Mannucci, and A Federici, and M Cattaneo, and R Fassati, and D Galmarini
Study of human von Willebrand factor immunogenicity in pigs with severe von Willebrand disease.
April 2005, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
P Mannuccio Mannucci, and A Federici, and M Cattaneo, and R Fassati, and D Galmarini
How I manage severe von Willebrand disease.
November 2019, British journal of haematology,
P Mannuccio Mannucci, and A Federici, and M Cattaneo, and R Fassati, and D Galmarini
Prophylaxis escalation in severe von Willebrand disease: a prospective study from the von Willebrand Disease Prophylaxis Network.
September 2015, Journal of thrombosis and haemostasis : JTH,
P Mannuccio Mannucci, and A Federici, and M Cattaneo, and R Fassati, and D Galmarini
Homozygous C2362F von Willebrand factor induces intracellular retention of mutant von Willebrand factor resulting in autosomal recessive severe von Willebrand disease.
May 2006, British journal of haematology,
P Mannuccio Mannucci, and A Federici, and M Cattaneo, and R Fassati, and D Galmarini
von Willebrand disease and von Willebrand factor.
May 2022, Haemophilia : the official journal of the World Federation of Hemophilia,
P Mannuccio Mannucci, and A Federici, and M Cattaneo, and R Fassati, and D Galmarini
Von Willebrand factor and von Willebrand disease.
December 2001, Reviews in clinical and experimental hematology,
Copied contents to your clipboard!